FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2886584397> ?p ?o ?g. }

• W2886584397 endingPage "458" @default.
• W2886584397 startingPage "452" @default.
• W2886584397 abstract "ObjectiveTo determine whether an association exists between maternal antithyroid antibodies and euploid miscarriage in women with recurrent early pregnancy loss (REPL).DesignObservational cohort study.SettingTwo academic medical centers.Patient(s)Women seen between 2004-2015 with a history of REPL, who were euthyroid or had subclinical hypothyroidism, had maternal antithyroid antibody testing and had at least one subsequent early pregnancy loss (<10 weeks' gestation).Intervention(s)Thyroid function and antibodies were measured at consultation. Subsequent miscarriages were assessed by conventional cytogenetic analysis, and when indicated, microsatellite analysis and/or comparative genomic hybridization/single nucleotide polymorphisms were performed.Main Outcome Measure(s)Determine whether maternal antithyroid antibodies are associated with euploid miscarriage.Result(s)Cohort consisted of 74 subjects with REPL who had 130 subsequent early pregnancy losses. The prevalence of maternal antithyroid antibodies in the cohort was 17.6%. Mean TSH was significantly higher among subjects with maternal antithyroid antibodies. Otherwise, no significant differences in demographics were noted. When comparing types of early pregnancy losses between the two groups, a trend toward having more miscarriages than nonvisualized pregnancy losses was noted among subjects with maternal antithyroid antibodies (70% and 30%) compared with subjects without maternal antithyroid antibodies (55% and 43%). No significant difference was noted in the frequency of euploid miscarriage between subjects with and without maternal antithyroid antibodies (42% vs. 56%).Conclusion(s)Our study did not demonstrate an association between euploid miscarriage and maternal antithyroid antibodies in subjects with a history of REPL. Therefore, testing or treatment in this cohort may not be warranted. To determine whether an association exists between maternal antithyroid antibodies and euploid miscarriage in women with recurrent early pregnancy loss (REPL). Observational cohort study. Two academic medical centers. Women seen between 2004-2015 with a history of REPL, who were euthyroid or had subclinical hypothyroidism, had maternal antithyroid antibody testing and had at least one subsequent early pregnancy loss (<10 weeks' gestation). Thyroid function and antibodies were measured at consultation. Subsequent miscarriages were assessed by conventional cytogenetic analysis, and when indicated, microsatellite analysis and/or comparative genomic hybridization/single nucleotide polymorphisms were performed. Determine whether maternal antithyroid antibodies are associated with euploid miscarriage. Cohort consisted of 74 subjects with REPL who had 130 subsequent early pregnancy losses. The prevalence of maternal antithyroid antibodies in the cohort was 17.6%. Mean TSH was significantly higher among subjects with maternal antithyroid antibodies. Otherwise, no significant differences in demographics were noted. When comparing types of early pregnancy losses between the two groups, a trend toward having more miscarriages than nonvisualized pregnancy losses was noted among subjects with maternal antithyroid antibodies (70% and 30%) compared with subjects without maternal antithyroid antibodies (55% and 43%). No significant difference was noted in the frequency of euploid miscarriage between subjects with and without maternal antithyroid antibodies (42% vs. 56%). Our study did not demonstrate an association between euploid miscarriage and maternal antithyroid antibodies in subjects with a history of REPL. Therefore, testing or treatment in this cohort may not be warranted." @default.
• W2886584397 created "2018-08-22" @default.
• W2886584397 creator A5007808194 @default.
• W2886584397 creator A5014321174 @default.
• W2886584397 creator A5024846196 @default.
• W2886584397 creator A5079116742 @default.
• W2886584397 creator A5081072784 @default.
• W2886584397 date "2018-08-01" @default.
• W2886584397 modified "2023-10-05" @default.
• W2886584397 title "Maternal antithyroid antibodies and euploid miscarriage in women with recurrent early pregnancy loss" @default.
• W2886584397 cites W1664347651 @default.
• W2886584397 cites W1852269776 @default.
• W2886584397 cites W1987184305 @default.
• W2886584397 cites W2013844042 @default.
• W2886584397 cites W2016236854 @default.
• W2886584397 cites W2039786614 @default.
• W2886584397 cites W2044835071 @default.
• W2886584397 cites W2046078778 @default.
• W2886584397 cites W2054330426 @default.
• W2886584397 cites W2089734665 @default.
• W2886584397 cites W2110657082 @default.
• W2886584397 cites W2117801166 @default.
• W2886584397 cites W2124173888 @default.
• W2886584397 cites W2161112687 @default.
• W2886584397 cites W2161857118 @default.
• W2886584397 cites W2329719919 @default.
• W2886584397 cites W2521554041 @default.
• W2886584397 cites W4238278966 @default.
• W2886584397 cites W4238799758 @default.
• W2886584397 cites W4293861220 @default.
• W2886584397 doi "https://doi.org/10.1016/j.fertnstert.2018.04.026" @default.
• W2886584397 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30098697" @default.
• W2886584397 hasPublicationYear "2018" @default.
• W2886584397 type Work @default.
• W2886584397 sameAs 2886584397 @default.
• W2886584397 citedByCount "14" @default.
• W2886584397 countsByYear W28865843972019 @default.
• W2886584397 countsByYear W28865843972020 @default.
• W2886584397 countsByYear W28865843972021 @default.
• W2886584397 countsByYear W28865843972022 @default.
• W2886584397 countsByYear W28865843972023 @default.
• W2886584397 crossrefType "journal-article" @default.
• W2886584397 hasAuthorship W2886584397A5007808194 @default.
• W2886584397 hasAuthorship W2886584397A5014321174 @default.
• W2886584397 hasAuthorship W2886584397A5024846196 @default.
• W2886584397 hasAuthorship W2886584397A5079116742 @default.
• W2886584397 hasAuthorship W2886584397A5081072784 @default.
• W2886584397 hasBestOaLocation W28865843971 @default.
• W2886584397 hasConcept C126322002 @default.
• W2886584397 hasConcept C131872663 @default.
• W2886584397 hasConcept C159654299 @default.
• W2886584397 hasConcept C163764329 @default.
• W2886584397 hasConcept C201903717 @default.
• W2886584397 hasConcept C203014093 @default.
• W2886584397 hasConcept C2776606491 @default.
• W2886584397 hasConcept C2776652619 @default.
• W2886584397 hasConcept C2777195454 @default.
• W2886584397 hasConcept C2778642596 @default.
• W2886584397 hasConcept C2778840127 @default.
• W2886584397 hasConcept C2779234561 @default.
• W2886584397 hasConcept C2779245376 @default.
• W2886584397 hasConcept C29456083 @default.
• W2886584397 hasConcept C2993291352 @default.
• W2886584397 hasConcept C46973012 @default.
• W2886584397 hasConcept C50181227 @default.
• W2886584397 hasConcept C526584372 @default.
• W2886584397 hasConcept C54355233 @default.
• W2886584397 hasConcept C71924100 @default.
• W2886584397 hasConcept C72563966 @default.
• W2886584397 hasConcept C86803240 @default.
• W2886584397 hasConceptScore W2886584397C126322002 @default.
• W2886584397 hasConceptScore W2886584397C131872663 @default.
• W2886584397 hasConceptScore W2886584397C159654299 @default.
• W2886584397 hasConceptScore W2886584397C163764329 @default.
• W2886584397 hasConceptScore W2886584397C201903717 @default.
• W2886584397 hasConceptScore W2886584397C203014093 @default.
• W2886584397 hasConceptScore W2886584397C2776606491 @default.
• W2886584397 hasConceptScore W2886584397C2776652619 @default.
• W2886584397 hasConceptScore W2886584397C2777195454 @default.
• W2886584397 hasConceptScore W2886584397C2778642596 @default.
• W2886584397 hasConceptScore W2886584397C2778840127 @default.
• W2886584397 hasConceptScore W2886584397C2779234561 @default.
• W2886584397 hasConceptScore W2886584397C2779245376 @default.
• W2886584397 hasConceptScore W2886584397C29456083 @default.
• W2886584397 hasConceptScore W2886584397C2993291352 @default.
• W2886584397 hasConceptScore W2886584397C46973012 @default.
• W2886584397 hasConceptScore W2886584397C50181227 @default.
• W2886584397 hasConceptScore W2886584397C526584372 @default.
• W2886584397 hasConceptScore W2886584397C54355233 @default.
• W2886584397 hasConceptScore W2886584397C71924100 @default.
• W2886584397 hasConceptScore W2886584397C72563966 @default.
• W2886584397 hasConceptScore W2886584397C86803240 @default.
• W2886584397 hasIssue "3" @default.
• W2886584397 hasLocation W28865843971 @default.
• W2886584397 hasLocation W28865843972 @default.
• W2886584397 hasOpenAccess W2886584397 @default.
• W2886584397 hasPrimaryLocation W28865843971 @default.
• W2886584397 hasRelatedWork W2020924677 @default.

• next